Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-17
DOI
10.1038/s41598-019-51287-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NK cell therapy for hematologic malignancies
- (2018) Rohtesh S. Mehta et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia
- (2018) Wen-Ting Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
- (2018) Folashade Otegbeye et al. PLoS One
- Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
- (2018) Jodi Chiu et al. Frontiers in Immunology
- IL-2 mediates NK cell proliferation but not hyperactivity
- (2017) Richa Sharma et al. IMMUNOLOGIC RESEARCH
- Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival
- (2017) Matteo Donadon et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma
- (2017) Kristina von Heyking et al. Molecular Oncology
- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
- (2017) Sarah Parisi et al. Frontiers in Immunology
- A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
- (2017) Juliane Wagner et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Expanded and armed natural killer cells for cancer treatment
- (2016) Noriko Shimasaki et al. CYTOTHERAPY
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds
- (2015) K. Lagrue et al. BLOOD
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
- (2014) W. Leung CLINICAL CANCER RESEARCH
- The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
- (2014) Antoine Marçais et al. NATURE IMMUNOLOGY
- Clinical utility of natural killer cells in cancer therapy and transplantation
- (2014) David A. Knorr et al. SEMINARS IN IMMUNOLOGY
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Metabolic Pathways in Immune Cell Activation and Quiescence
- (2013) Erika L. Pearce et al. IMMUNITY
- Irradiated and Activated Autologous PBMCs Induce Expansion of Highly Cytotoxic Human NK Cells In Vitro
- (2013) Yong-Oon Ahn et al. JOURNAL OF IMMUNOTHERAPY
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation
- (2013) Jeanne M Palmer et al. Journal of Cancer
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
- (2012) A. Glasner et al. JOURNAL OF IMMUNOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Natural killer cell distribution and trafficking in human tissues
- (2012) Paolo Carrega et al. Frontiers in Immunology
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- Activating and inhibitory receptors of natural killer cells
- (2010) Hollie J Pegram et al. IMMUNOLOGY AND CELL BIOLOGY
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
- (2010) Vivien Béziat et al. PLoS One
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now